Evidence for endogenous formation of tobacco-specific nitrosamines in rats treated with tobacco alkaloids and sodium nitrite

Carcinogenesis

Volumn 18, Issue 3, 1997, Pages 587-592

  Carmella, Steven G ^a,b   Borukhova, Anna ^a   Desai, Dhimant ^a   Hecht, Stephen S ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BUTANONE; ALKALOID; ANABASINE; CARCINOGEN; NITROSAMINE; NORNICOTINE; SODIUM NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; NITROSATION; NONHUMAN; PRIORITY JOURNAL; RAT; TOBACCO; URINALYSIS;

ALKALOIDS; ANIMALS; BIOTRANSFORMATION; DRUG SYNERGISM; GLUCURONATES; MALE; NICOTINE; NITROSAMINES; PLANT EXTRACTS; PLANTS, TOXIC; RATS; RATS, INBRED F344; SODIUM NITRITE; TOBACCO;

EID: 0031408864     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.3.587     Document Type: Article

References (51)

1. Hoffmann, D. and Hecht, S.S. (1985) Nicotine-derived N-nitrosamines and tobacco related cancer: current status and future directions. Cancer Res., 45, 935-944.
2. Hecht, S.S. and Hoffmann, D. (1988) Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis, 9, 875-884.
3. Hecht, S.S. and Hoffmann, D. (1989) The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv., 8, 273-294.
4. Hoffmann, D., Brunnemann, K.D., Prokopczyk, B. and Djordjevic, M.V. (1994) Tobacco-specific N-nitrosamines and areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J. Toxicol. Environ. Hlth, 41, 1-52.
5. Mirvish, S.S. (1975) Formation of N-nitroso compounds: chemistry, kinetics, and in vivo occurrence. Toxicol. Appl. Pharmacol., 31, 325-351.
6. Assembly of Life Sciences (1988) The Health Effects of Nitrate, Nitrite, and N-Nitroso Compounds. National Academy Press, Washington, DC, Ch. 8.
7. Marletta, M.A. (1988) Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents. Chem. Res. Toxicol., 1, 249-257.
8. Bartsch, H., Ohshima, H., Pignatelli, B. and Calmels, S. (1989) Human exposure to endogenous N-nitroso compounds: quantitative estimates in subjects at high risk for cancer of the oral cavity, oesophagus, stomach and urinary bladder. Cancer Surv., 8, 335-362.
9. Hecht, S.S., Chen, C.B., Ornaf, R.M., Jacobs, E., Adams, J.D. and Hoffmann, D. (1978) Reaction of nicotine and sodium nitrite: formation of nitrosamines and fragmentation of the pyrrolidine ring. J. Org. Chem., 43, 72-76.
10. Caldwell, W.S., Greene, J.M., Plowchalk, D.R. and deBethizy, J.D. (1991) The nitrosation of nicotine: a kinetic study. Chem. Res. Toxicol., 4, 513-516.
11. Mirvish, S.S., Sams, J. and Hecht, S.S. (1977) Kinetics of nornicotine and anabasine nitrosation in relation to N′-nitrosonornicotine occurrence in tobacco and to tobacco-induced cancer. J. Natl Cancer Inst., 59, 1211-1213.
12. Tricker, A.R., Haubner, R., Spiegelhalder, B. and Preussmann, R. (1988) The occurrence of tobacco-specific nitrosamines in oral tobacco products and their potential formation under simulated gastric conditions. Fd Chem. Toxicol., 26, 861-865.
13. Djordjevic, M.V., Sigountos, C.W., Brunnemann, K.D. and Hoffmann, D. (1991) Formation of 4-(methylnitrosamino)-4-(3-pyridyl)butyric acid in vitro and in mainstream cigarette smoke. J. Agric. Fd Chem., 39, 209-213.
14. Tricker, A.R., Scherer, G., Conze, C., Adlkofer, F., Pachinger, A. and Klus, H. (1993) Evaluation of 4-(N-methylnitrosamino)-4-(3-pyridyl)butyric acid as a potential monitor of endogenous nitrosation of nicotine and its metabolites. Carcinogenesis, 14, 1409-1414.
15. Morse, M.A., Eklind, K.I., Toussaint, M., Amin, S.G. and Chung, F.-L. (1990) Characterization of a glucuronide metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis, 11, 1819-1823.
16. Carmella, S.G., Akerkar, S. and Hecht, S.S. (1993) Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res., 53, 721-724.
17. Hu, M.W., Bondinell, W.E. and Hoffmann, D. (1974) Synthesis of carbon 14-labelled myosmine, nornicotine, and N′-nitrosonornicotine. J. Labelled Compounds, 10, 79-88.
18. Seeman, J.I., Secor, H.V., Whidby, J.F. and Bassfield, R.L. (1978) Menschutkin reaction stereoselectivities of nicotine and related compounds. Tetrahedron Lett., 1901-1904.
19. Quan, P.M., Karns, T.K.B. and Quin, L.D. (1965) The synthesis of anatabine and related compounds. J. Org. Chem., 30, 2769-2772.
20. Bowman, E.R. and McKennis, H., Jr. (1963) (-)Cotinine. Biochem. Preparat., 10, 36-39.
21. Hecht, S.S., Young, R. and Chen, C.B. (1980) Metabolism in the F344 rat of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen. Cancer Res., 40, 4144-4150.
22. Hecht, S.S., Ornaf, R.M. and Hoffmann, D. (1974) N′-Nitrosonornicotine in tobacco: analysis of possible contributing factors and biologic implications. J. Natl Cancer Inst., 54, 1237-1244.
23. Hoffmann, D., Adams, J.D., Brunnemann, K.D. and Hecht, S.S. (1979) Assessment of tobacco-specific N-nitrosamines in tobacco products. Cancer Res., 39, 2505-2509.
24. Hecht, S.S., Radok, L., Amin, S., Huie, K., Melikian, A.A., Hoffmann, D., Pataki, J. and Harvey, R.G. (1985) Tumorigenicity of 5-methylchrysene dihydrodiols and dihydrodiol epoxides in newborn mice and on mouse skin. Cancer Res., 45, 1449-1452.
25. Hoffmann, D., Raineri, R., Hecht, S.S., Maronpot, R. and Wynder, E.L. (1975) Effects of N′-nitrosonornicotine and N′-nitrosoanabasine in rats. J. Natl Cancer Inst., 55, 977-981.
26. Hoffmann, D., Rivenson, A., Amin, S. and Hecht, S.S. (1984) Dose-response study of the carcinogenicity of tobacco-specific N-nitrosamines in F344 rats. J. Cancer Res. Clin. Oncol., 108, 81-86.
27. Hilfrich, J., Hecht, S.S. and Hoffmann, D. (1977) Effects of N′-nitrosonornicotine and N′-nitrosoanabasine in Syrian golden hamsters. Cancer Lett., 2, 169-176.
28. Hecht, S.S., Young, R. and Maeura, Y. (1983) Comparative carcinogenicity in F344 rats and Syrian golden hamsters of N′-nitrosonornicotine and N′-nitrosonornicotine-1-N-oxide. Cancer Lett., 20, 333-340.
29. Castonguay, A., Rivenson, A., Trushin, N., Reinhardt, J., Spathopoulos, S., Weiss, C.J., Reiss, B. and Hecht, S.S. (1984) Effects of chronic ethanol consumption on the metabolism and carcinogenicity of N′-nitrosonornicotine in F344 rats. Cancer Res., 44, 2285-2290.
30. Hecht, S.S., Chen, C.B., Hirota, N., Ornaf, R.M., Tso, T.C. and Hoffmann, D. (1978) Tobacco specific nitrosamines: formation from nicotine in vitro and during tobacco curing and carcinogenicity in strain A mice. J. Natl Cancer Inst., 60, 819-824.
31. Castonguay, A., Lin, D., Stoner, G.D., Radok, P., Furuya, K., Hecht, S.S., Schut, H.A.J. and Klaunig, J.E. (1983) Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N′-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their analogues. Cancer Res., 43, 1223-1229.
32. McCoy, G.D., Hecht, S.S., Katayama, S. and Wynder, E.L. (1981) Differential effect of chronic ethanol consumption on the carcinogenicity of N-nitrosopyrrolidine and N′-nitrosonornicotine in male Syrian golden hamsters. Cancer Res., 41, 2849-2854.
33. Hoffmann, D., Castonguay, A., Rivenson, A. and Hecht, S.S. (1981) Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonomicotine in Syrian golden hamsters. Cancer Res., 41, 2386-2393.
34. Koppang, N., Rivenson, A., Reith, A., Dahle, H.K., Evensen, O. and Hoffmann, D. (1992) A study of tobacco carcinogenesis XLVIII. Carcinogenicity of N′-nitrosonornicotine in mink (Mustela vison). Carcinogenesis, 13, 1957-1960.
35. Chen, C.B., Hecht, S.S. and Hoffmann, D. (1978) Metabolic α-hydroxylation of the tobacco specific carcinogen, N′-nitrosonornicotine. Cancer Res., 38, 3639-3645.
36. Hecht, S.S., Lin, D. and Chen, C.B. (1981) Comprehensive analysis of urinary metabolites of N′-nitrosonornicotine. Carcinogenesis, 2, 833-838.
37. Hecht, S.S., Spratt, T.E. and Trushin, N. (1988) Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine. Carcinogenesis, 9, 161-165.
38. Kyerematen, G.A., Taylor, L.H., deBethizy, J.D. and Vesell, E.S. (1987) Radiometric-high performance liquid chromatographic assay for nicotine and twelve of its metabolites. J. Chromatogr., 419, 191-203.
39. Crooks, P.A., Li, M. and Dworkin, L.P. (1995) Determination of nicotine metabolites in rat brain after peripheral radiolabeled nicotine administration: detection of nornicotine. Drug Metab. Dispos., 23, 1175-1177.
40. Hecht, S.S. and Young, R. (1982) Regiospecificity in the metabolism of the homologous cyclic nitrosamines, N′-nitrosonornicotine and N′-nitrosoanabasine. Carcinogenesis, 3, 1195-1199.
41. Boyland, E., Roe, F.J.C., Gorrod, J.W. and Mitchley, B.C.V. (1964) The carcinogenicity of nitrosoanabasine, a possible constituent of tobacco smoke. Br. J. Cancer, 18, 265-270.
42. Hoffmann, D., Djordjevic, M.V., Rivenson, A., Desai, D. and Amin, S. (1993) Relative potencies of tobacco-specific N-nitrosamines as inducers of lung tumors in A/J mice. Cancer Lett., 71, 25-30.
43. Schmeltz, I. and Hoffmann, D. (1977) Nitrogen containing compounds in tobacco and tobacco smoke. Chem. Rev., 77, 295-311.
44. International Agency for Research on Cancer (1986) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38, Tobacco Smoking. IARC, Lyon, France, p. 93.
45. Tannenbaum, S.R., Weisman, M. and Fett, D. (1976) The effect of nitrate intake on nitrite formation in human saliva. Fd Cosmet. Toxicol., 14, 549-552.
46. Liu, R.H. and Hotchkiss, J.H. (1995) Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat. Res., 339, 73-89.
47. Gora, M.L. (1993) Nicotine transdermal systems. Annls Pharmacother., 27, 742-749.
48. Rose, J.E., Levin, E.D. and Benowitz, N. (1993) Saliva nicotine as an index of plasma levels in nicotine patch users. Therapeutic Drug Monitoring, 15, 431-435.
49. Benowitz, N.L., Jacob, P., Fong, I. and Gupta, S. (1994) Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J. Pharmacol. Exp. Ther., 268, 296-303.
50. Kyerematen, G.A., Morgan, M.L., Chattopadhyay, B., deBethizy, J.D. and Vesell, E.S. (1990) Disposition of nicotine and eight metabolites in smokers and nonsmokers: identification in smokers of two metabolites that are longer lived than cotinine. Clin. Pharmacol. Ther., 48, 641-651.
51. US Surgeon General (1988) The Health Consequences of Smoking: Nicotine Addiction. US Department of Health and Human Services, US Government Printing Office, Washington, DC.